Ranbaxy, an importer of generic pharmaceuticals, sought a declaration of non infringement and revocation of EP 1 020 461 owned by AstraZeneca. AstraZeneca counterclaimed for infringement.
Kitchin J discussed the prohibition from patentability any method of treatment of humans or animals, and the attempts to circumvent this by casting therapeutic claims a manufacturing ones, so called Swiss form claims.
 EWHC 1831 (Pat),  FSR 45
England and Wales
Cited – Eli Lilly v Actavis UK Ltd and Others SC 12-Jul-2017
The issue raised on this appeal and cross-appeal is whether three products manufactured by Actavis would infringe a patent whose proprietor is Lilly, namely European Patent (UK) No 1 313 508, and its corresponding designations in France, Italy and . .
These lists may be incomplete.
Updated: 17 February 2021; Ref: scu.441879